FDA Inspection 906256 — Hospira, Inc.
The FDA completed an inspection of Hospira, Inc. on Dec 9, 2014 in Lake Forest, IL. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Dec 9, 2014
- Fiscal Year
- 2015
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Lake Forest, IL (United States)